Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (303)
Connect Biopharma Holdings Ltd (CNTB)
Huang James — Director
Shares
1,160,000
Price
$3.45
Total Value
$4.00M
Shares Held After
13,160,000
% of Holdings
8.8%
Zenas BioPharma, Inc. (ZBIO)
Fairmount Funds Management LLC — Director
Shares
150,000
Price
$20.00
Total Value
$3.00M
Shares Held After
2,359,025
% of Holdings
6.4%
Tonix Pharmaceuticals Holding Corp. (TNXP)
LEDERMAN SETH — Director
Shares
5,000
Price
$12.62
Total Value
$63.10K
Shares Held After
20,001
% of Holdings
25.0%
CURIS INC (CRIS)
KAITIN KENNETH I — Director
Shares
10,000
Price
$0.55
Total Value
$5.49K
Shares Held After
11,407
% of Holdings
87.7%
Nasus Pharma Ltd (NSRX)
Teleman Dan Benjamin — Director
Shares
15,000
Price
$2.04
Total Value
$30.60K
Shares Held After
21,246
% of Holdings
70.6%
Cogent Biosciences, Inc. (COGT)
Fairmount Funds Management LLC — Director
Shares
7,000,000
Price
$34.66
Total Value
$242.62M
Shares Held After
5,503,418
% of Holdings
56.0%
ABEONA THERAPEUTICS INC. (ABEO)
Seshadri Vishwas — Director
Shares
29,985
Price
$4.38
Total Value
$131.48K
Shares Held After
1,430,423
% of Holdings
2.1%
Zenas BioPharma, Inc. (ZBIO)
MOULDER LEON O JR — Director
Shares
34,000
Price
$19.31
Total Value
$656.54K
Shares Held After
1,726,039
% of Holdings
2.0%
Edgewise Therapeutics, Inc. (EWTX)
Donovan Joanne M. — CMO
Shares
21,338
Price
$32.12
Total Value
$685.31K
Shares Held After
9,597
% of Holdings
69.0%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$13.45
Total Value
$256.36K
Shares Held After
455,878
% of Holdings
4.0%
Zenas BioPharma, Inc. (ZBIO)
Lu Hongbo — Director
Shares
75,000
Price
$20.00
Total Value
$1.50M
Shares Held After
422,968
% of Holdings
17.7%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
67,991
Price
$4.88
Total Value
$331.80K
Shares Held After
431,094
% of Holdings
13.6%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
3,639
Price
$65.00
Total Value
$236.53K
Shares Held After
66,004
% of Holdings
5.2%
ANAPTYSBIO, INC (ANAB)
Schmid John P. — Director
Shares
522
Price
$57.40
Total Value
$29.96K
Shares Held After
31,622
% of Holdings
1.6%
ANAPTYSBIO, INC (ANAB)
Schmid John P. — Director
Shares
7,527
Price
$56.70
Total Value
$426.78K
Shares Held After
32,144
% of Holdings
19.0%
ANAPTYSBIO, INC (ANAB)
Schmid John P. — Director
Shares
12,596
Price
$55.71
Total Value
$701.71K
Shares Held After
39,671
% of Holdings
24.1%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
25,000
Price
$22.37
Total Value
$559.23K
Shares Held After
986,667
% of Holdings
2.5%
Xeris Biopharma Holdings, Inc. (XERS)
Brady James Aloysius — Director
Shares
10,834
Price
$5.54
Total Value
$60.04K
Shares Held After
89,166
% of Holdings
10.8%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
790
Price
$30.02
Total Value
$23.71K
Shares Held After
10,503
% of Holdings
7.0%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
6,710
Price
$29.26
Total Value
$196.31K
Shares Held After
11,293
% of Holdings
37.3%
Dyne Therapeutics, Inc. (DYN)
Posner Brian S — Director
Shares
2,000
Price
$17.08
Total Value
$34.16K
Shares Held After
15,500
% of Holdings
12.9%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
2,968
Price
$98.13
Total Value
$291.25K
Shares Held After
58,117
% of Holdings
4.9%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
2,532
Price
$97.43
Total Value
$246.69K
Shares Held After
61,085
% of Holdings
4.0%
PALVELLA THERAPEUTICS, INC. (PVLA)
JENKINS GEORGE M — Director
Shares
445
Price
$112.30
Total Value
$49.97K
Shares Held After
187,616
% of Holdings
0.2%
Zenas BioPharma, Inc. (ZBIO)
MOULDER LEON O JR — Director
Shares
20,000
Price
$18.23
Total Value
$364.60K
Shares Held After
1,692,039
% of Holdings
1.2%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$12.63
Total Value
$240.73K
Shares Held After
460,216
% of Holdings
4.0%
Rezolute, Inc. (RZLT)
Evans Daron — CFO
Shares
10,000
Price
$2.85
Total Value
$28.50K
Shares Held After
414,462
% of Holdings
2.4%
PRECIGEN, INC. (PGEN)
KIRK RANDAL J — Director
Shares
2,334,420
Price
$3.30
Total Value
$7.70M
Shares Held After
12,262,741
% of Holdings
16.0%
PRECIGEN, INC. (PGEN)
KIRK RANDAL J — Director
Shares
23,789
Price
$3.30
Total Value
$78.50K
Shares Held After
423,984
% of Holdings
5.3%
PRECIGEN, INC. (PGEN)
KIRK RANDAL J — Director
Shares
38,976
Price
$3.30
Total Value
$128.62K
Shares Held After
302,213
% of Holdings
11.4%
PRECIGEN, INC. (PGEN)
KIRK RANDAL J — Director
Shares
47,101
Price
$3.30
Total Value
$155.43K
Shares Held After
519,061
% of Holdings
8.3%
PRECIGEN, INC. (PGEN)
KIRK RANDAL J — Director
Shares
168,794
Price
$3.30
Total Value
$557.02K
Shares Held After
1,425,544
% of Holdings
10.6%
PRECIGEN, INC. (PGEN)
KIRK RANDAL J — Director
Shares
426,199
Price
$3.30
Total Value
$1.41M
Shares Held After
3,358,917
% of Holdings
11.3%
PRECIGEN, INC. (PGEN)
KIRK RANDAL J — Director
Shares
50,797
Price
$3.30
Total Value
$167.63K
Shares Held After
425,732
% of Holdings
10.7%
PRECIGEN, INC. (PGEN)
KIRK RANDAL J — Director
Shares
152,063
Price
$3.30
Total Value
$501.81K
Shares Held After
1,463,571
% of Holdings
9.4%
PRECIGEN, INC. (PGEN)
KIRK RANDAL J — Director
Shares
370,847
Price
$3.30
Total Value
$1.22M
Shares Held After
3,238,210
% of Holdings
10.3%
PRECIGEN, INC. (PGEN)
KIRK RANDAL J — Director
Shares
50,797
Price
$3.30
Total Value
$167.63K
Shares Held After
426,695
% of Holdings
10.6%
PRECIGEN, INC. (PGEN)
KIRK RANDAL J — Director
Shares
1,108,998
Price
$3.30
Total Value
$3.66M
Shares Held After
80,672,818
% of Holdings
1.4%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
15,536
Price
$5.10
Total Value
$79.23K
Shares Held After
499,085
% of Holdings
3.0%
INSMED Inc (INSM)
Smith Michael Alexander — Chief Legal Officer
Shares
19,638
Price
$150.98
Total Value
$2.96M
Shares Held After
51,871
% of Holdings
27.5%
Polyrizon Ltd. (PLRZ)
Carmel Liron — Director
Shares
100
Price
$11.00
Total Value
$1.10K
Shares Held After
4,069
% of Holdings
2.4%
Mineralys Therapeutics, Inc. (MLYS)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
58,300
Price
$24.16
Total Value
$1.41M
Shares Held After
5,825,521
% of Holdings
1.0%
Polyrizon Ltd. (PLRZ)
Turgeman Tidhar — Director
Shares
2,917
Price
$10.90
Total Value
$31.80K
Shares Held After
17,518
% of Holdings
14.3%
Polyrizon Ltd. (PLRZ)
Izraeli Tomer — Director
Shares
3,900
Price
$10.90
Total Value
$42.51K
Shares Held After
32,012
% of Holdings
10.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
21
Price
$606.53
Total Value
$12.74K
Shares Held After
18,876
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
770
Price
$604.64
Total Value
$465.57K
Shares Held After
18,897
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
103
Price
$603.69
Total Value
$62.18K
Shares Held After
19,667
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
417
Price
$602.53
Total Value
$251.26K
Shares Held After
19,770
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
212
Price
$601.43
Total Value
$127.50K
Shares Held After
20,187
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
790
Price
$599.82
Total Value
$473.86K
Shares Held After
20,399
% of Holdings
3.7%
Showing 151–200 of 303 transactions (page 4 of 7)